Research increasingly suggests that when a woman with obesity becomes pregnant, a process of “fetal reprogramming” increases the risk that her baby will face problems like obesity, Type 2 diabetes and liver disease earlier in life. To better understand how that reprogramming occurs, University of Oklahoma researchers recently earned a $2.3 million grant from the National Institutes of Health. They also will study whether an antioxidant called PQQ given to the mother can lower the risk of future metabolic problems for her offspring.

Dr. Nancy Halliday, a David Ross Boyd Professor in the Department of Cell Biology in the College of Medicine has been named the University of Oklahoma College of Medicine’s 2024 Stanton L. Young Master Teacher.

An innovative new field of research holds the promise for pediatric cardiologists and heart surgeons to predict the future structural integrity of a child’s heart valves so they can perform the best possible surgery today. At the University of Oklahoma, a pediatric heart surgeon and cardiologist are collaborating with a biomedical engineer in a type of research that few in the nation are doing.
 

University of Oklahoma College of Medicine researcher Paul L. DeAngelis, Ph.D., has been awarded the President’s Innovator Award by the Society for Glycobiology.

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer.